查詢結果分析
來源資料
相關文獻
- Intracoronary β-Irradiation with Liquid Rhenium-188 to Prevent Restenosis Following Pure Balloon Angioplasty: Results from the TRIPPER-1 Study
- Preliminary Experience with the NIR Coronary Stent in Kaohsiung Veterans General Hospital
- 放射線對血管再狹窄的預防
- Fracture of a Reused Balloon Catheter during Coronary Angioplasty
- 血管基因治療法
- 血管內近接放射線治療對血管再狹窄之預防:現狀與前景
- Perioperative Result of Carotid Endarterectomies with Venous Patch Angioplasty
- Prognosis of Coronary Arterial Lesions in Kawasaki Disease Treated without Intravenous Immunoglobulin
- Elective Coronary Stenting for Unprotected Left Main Stenosis--A Case Report
- □Re液體貝他射源於血管近接治療之劑量評估與量測技術
頁籤選單縮合
題 名 | Intracoronary β-Irradiation with Liquid Rhenium-188 to Prevent Restenosis Following Pure Balloon Angioplasty: Results from the TRIPPER-1 Study=施行線液態錸-188照射以防止經血管氣球擴張術後之冠狀動脈再狹窄--TRIPPER-1研究的結果 |
---|---|
作 者 | 洪志凌; 傅懋洋; 謝柏滄; 梁雲; 吳炯仁; 丁幹; | 書刊名 | 長庚醫學 |
卷 期 | 26:2 2003.02[民92.02] |
頁 次 | 頁98-106 |
分類號 | 415.3161 |
關鍵詞 | 血管整形術; 再狹窄; 冠狀動脈病變; 進階放射治療; Angioplasty; Restenosis; Coronary artery disease; Brachytherapy; |
語 文 | 英文(English) |
中文摘要 | 背景:接受皮冠狀動脈血管形成術的患者,常因六月個月內標的血管再狹窄而困擾。氣球擴張術後施行冠狀動脈放線照射已顯示能改變血管再狹窄的反應。 方法:臺灣以放射線防止經皮冠狀動脈九球擴張術後之再狹窄研究-I (TRIPPER-I Study),評估接受冠狀動脈氣球擴張術後使用個我置中貝它放射同位素液態錸-188灌氣球治療既安全性與可行性及經六個月後血管的再狹窄率。 結果:40病患接受液態錸-188填充入灌流九球導管14格雷照射於0.5厘深的管壁組織,而有25安慰劑對照組病患接受灌流氣球導管在病灶維持5分鐘的膨脹時間。治療過程中並無併發症。住院中及30天的追蹤並無主不良心臟事故。39位錸-188組和25位控制組的病患接受六個月後血管的照相,檢查率分別為97.5%和100%。六個月後血管的再狹窄率線-188組為49%,控制組為56%(p=0.62)。死亡,心肌更塞,標的病灶再治療率的混合終點,錸-188組為40%,控制組為36%(p=0.80)。 結論:新的或狹窄的冠狀動脈病灶接受經冠狀動脈氣球擴張術後施行貝它放射線液態錸-188照射是可行的,但本研究未顯示14個雷照射於0.5厘深的管壁組織能有效防止經血管氣球擴張術後冠狀動脈再狹窄。 |
英文摘要 | Background: Patients who receive percutaneous transluminal coronary angioplasty (PTCA) are often haunted by resteosis of the target vessel within 6 months. Intracoronary irradiation has been show to alter the luminal narrowing response after balloon angioplasty. Methods: The Taiwan Radiation in Prevention of Post-Pure Balloon Angioplasty Restenosis-I (TRIPPER-I) study evaluated the feasibility, safety, and 6-month angiographic restenosis with intracoronary irradiation after pure balloon angioplasty (POBA) of de novo and post-POBA rrestentoic lesions in native coronary arteries using a self-contering β-emitter rhenium-188 (Re-188)-filled balloon. Results: Forty patients received 14 Gy at a 0.5-mm tissue depth with a Re-188 solution-filled perfusion balloon catheter, and 25 control patients received 5-min inflation with a perfusion balloon catheter. There were no procedural complications or in-hospital or 30-day major adverse cardiac events. Six-month angiographic follow-up was performed on 39 Re-188 (97.5%) and 25 control patients (100%). The restenosis rate was 49% in the Re-188 and 56% in the control groups (p=0.62). the composite end-points of death, myocardial infarction, and target-vessel revascularization were 40% in the Re-188 group and 36% in the control group (p=0.80). Conclusions: Catheter-based radiotherapy after POBA of de novo and post-POBA restenotic lesions with a Re-188-filled balloon is feasible but was ineffective in reducing target lesion restenosis a does of 14Gy delivered at a 0.5mm tissue depth in this study. |
本系統中英文摘要資訊取自各篇刊載內容。